Cannabis Medicines

Policy information

  • IB2019_041 Schedule 8 Cannabis Medicines and Unregistered Schedule 8 Medicines Information Bulletin. NSW Health. 16 October 2019.
  • NSW-based clinicians should obtain information tailored to the patient-specific clinical context from the NSW Cannabis Medicines Advisory Service¬†(NSW CMAS) including, but not limited to, clinical¬†and scientific evidence¬†and clinical trials.
  • Information on NSW-based regulatory requirements for prescription and supply of S8 Cannabis Medicines, including prescriber, dispensing and storage requirements is available from NSW Ministry of Health Pharmaceutical Services.


Other online resources